Last edition
News about "surgical site infections"
Xtant Medical Extends Orthobiologics Portfolio, Launches CollagenX for Surgical Wound Closure
Xtant Medical Holdings has announced the commercial launch of CollagenX, a bovine collagen particulate product designed for surgical wound closure, extending its orthobiologics portfolio.
Surgical Site Infections | 06/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members